Amgen’s Prolia receives FDA authorization for new indications to treat cancer patients Amgen today announced that the U.S. Aromatase inhibitors are often used in patients with breast cancer to prevent recurrence of disease, and androgen deprivation therapy can be often used in patients with prostate malignancy to prevent or control recurrent disease cialis brand or cialis generic . These remedies reduce hormone levels, resulting in bone loss and an increased risk of fracture. ‘Bone reduction and fractures are known adverse effects of hormone ablation therapies but we’ve not had an accepted treatment option to prevent these complications for our patients,’ said Matthew Smith, M.D., Ph.D., director of the Genitourinary Malignancies System at Massachusetts General Medical center Cancer Middle, Boston.
Globally, one in three females over 50 will knowledge a fracture in her lifetime, said Dr. Ethel Siris, director of the Toni Stabile Osteoporosis Center at Columbia University Medical Center and immediate past president of the National Osteoporosis Foundation. I am particularly worked up about these findings because they show that denosumab may give an important new option for patients. This long-awaited study demonstrated that denosumab treatment both elevated bone mass and decreased the risk of skeletal fractures in females with postmenopausal osteoporosis, said Roger M.